Inflammatory Pain Therapeutic Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Inflammatory Pain Therapeutic Market is segemented By Treatment (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Biologic Therapies, Other Analgesics), By Disease Indication (Rheumatoid Arthritis, Early-stage RA, Advanced RA, Osteoarthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Other Indications), (By End User Hospitals, Clinics, Diagnostic Centers, Research Institutes), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.
Inflammatory Pain Therapeutic Market Size
Market Size in USD
CAGR5.8%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 5.8% |
| Market Concentration | High |
| Major Players | Pfizer Inc., Roche Holding AG, Novartis AG, Johnson & Johnson, Merck & Co., Inc. |
please let us know !
Inflammatory Pain Therapeutic Market Analysis
The inflammatory pain therapeutic market is estimated to be valued at USD 4.76 billion in 2024 and is expected to reach USD 7.06 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.8% from 2024 to 2031.
There has been consistent rise in use of prescription drugs to manage inflammatory pain indicating growth in awareness and healthcare spending, which is driving the market growth.